Search

everythinglearnresearchcommunity

for

Search:↓

Dermoscopy is an effective tool for accurately detecting skin cancers.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Avoid high-tension styles and use professional treatments to reduce hair damage and health risks.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Finasteride caused enlarged breast tissue in a 62-year-old man.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Certain skin diseases are linked to Agent Orange and similar chemicals; veterans should be screened and informed about uncertain risks, and current data doesn't link spironolactone with breast cancer.

Hair analysis may help detect breast cancer early by identifying changes in lipid content.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Disruptions in mammary stem cell division can lead to cancer, but targeting these processes might help treat breast cancer.

Cetuximab can cause eyelash growth, which is rare but manageable.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.